Beyond Weekly Injections: Reimagining Long-Term Obesity Treatment Through Ultra-Long-Acting Drug Delivery

2:00 pm - Wednesday 9th December 2026

  • Examining how poor adherence and early treatment discontinuation contribute to suboptimal outcomes and rapid weight regain
  • Exploring whether continuous, long-acting drug exposure can improve tolerability and persistence by reducing fluctuations associated with missed doses
  • Evaluating the potential of reversible implant-based therapies to deliver durable efficacy with minimal patient burden while maintaining treatment flexibility and control

Speakers:

Chief Executive Officer
Vivani